CA057-008

Hematological neoplasms
Multiple myeloma
Follow-Up Treatment
A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480(BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480(BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)